131
Participants
Start Date
June 12, 2015
Primary Completion Date
April 30, 2019
Study Completion Date
January 30, 2020
Ekosonic® Endovascular Device ultrasonic infusion catheter
r-tPA will be administered via EKOS.
Recombinant tissue plasminogen activator
Recombinant tissue plasminogen activator will be administered as per the dose and schedule specified in the arm.
UPMC Hamot, Erie
Lankenau Medical Center, Wynnewood
Piedmont Hospital, Atlanta
University Hospital, Augusta
Tallahassee Memorial Hospital, Tallahassee
Florida Hospital Tampa, Tampa
Vanderbilt University Medical Center, Nashville
Jewish Hospital, Louisville
Mount Carmel Health System, Columbus
St. Vincent Medical Group, Indianapolis
Detroit Medical Center, Detroit
East Jefferson General Hospital, Metairie
Houston Methodist Sugarland Hospital, Richmond
Cedars Sinai, Beverly Hills
Providence Sacred Heart Medical Center, Spokane
Inova Alexandria Hospital, Alexandria
Royal Devon & Exeter Hospital, Exeter
Medway Maritime Hospital, Gillingham
Royal Free Hospital, London
St. Thomas Hospital, London
Ninewells Hospital, Dundee
Lead Sponsor
Collaborators (1)
EKOS Corporation
INDUSTRY
Boston Scientific Corporation
INDUSTRY